> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medtronic ‘Breakthrough’ for Lung Lesion Ablator
- URL: https://www.fdaweb.com/medtronic-breakthrough-for-lung-lesion-ablator/
- Published: 2021-04-27T12:00:00.000Z
- Updated: 2026-09-14T16:56:34.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5149197

FDA has granted Medtronic a breakthrough device designation for the Emprint ablation catheter kit, which is intended to be used in conjunction with the Emprint microwave generator and Medtronic lung navigation platform for localized treatment of malignant lesions in the lung. *“*Using an endoluminal approach, the Emprint ablation catheter kit will be studied with the Medtronic lung navigation system to allow for accurate delivery of microwave energy to the targeted lung lesion(s),” the company says. Clinical guidelines recommend local therapies such as thermal ablation in combination with systemic therapies when suitable, it adds.

  
Medtronic says its lung navigation platform enables precise and accurate placement of the ablation catheter within the target lesion. The device has been on the market for 15 years and used in 200,000 lung procedures.